Terms: = Ovarian cancer AND LYL1, P12980, 4066, ENSG00000104903 AND Staging
2 results:
1. KRAS mutations and endometriosis burden of disease.
Orr NL; Albert A; Liu YD; Lum A; Hong J; Ionescu CL; Senz J; Nazeran TM; Lee AF; Noga H; Lawrenson K; Allaire C; Williams C; Bedaiwy MA; Anglesio MS; Yong PJ
J Pathol Clin Res; 2023 Jul; 9(4):302-312. PubMed ID: 36977195
[TBL] [Abstract] [Full Text] [Related]
2. Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study.
Poncelet C; Fauvet R; Yazbeck C; Coutant C; Darai E
Eur J Surg Oncol; 2010 Nov; 36(11):1066-72. PubMed ID: 20817462
[TBL] [Abstract] [Full Text] [Related]
